Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 89 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8236832

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  2. US 8232406

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  3. US 8227516

    Compounds as histone deacetylase inhibitors

    4SC DISCOVERY GMBH · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  4. US 8222293

    Treating learning deficits with inhibitors of Hmg CoA reductase

    Regents of the University of Carolina · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted
  5. US 8222203

    Macrocyclic oximyl hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted
  6. US 8222411

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted
  7. US 8222288

    Small molecule inhibitors of MDM2 and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted
  8. US 8222215

    Methods for the use of inhibitors of antigen presentation by MHC class II molecules

    Provid Pharmaceuticals Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted
  9. US 8221737

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted
  10. US 8217056

    Triazolothiadiazole inhibitor of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  11. US 8217048

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted
  12. US 8211884

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  13. US 8211914

    Inhibitors of diacylglycerol acyltransferase

    Madrigal Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  14. US 8211891

    Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted
  15. US 8207142

    Inhibitor of DNA methylation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  16. US 8202889

    Inhibitors of bacterial IMPDH

    Vertex Pharmaceuticals Incorporated · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  17. US 8202990

    Polo-like kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  18. US 8202861

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted
  19. US 8193352

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  20. US 8193202

    LIMK2 inhibitors, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  21. US 8188134

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  22. US 8188289

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted May 29, 2012 · Expires May 24, 2032

    granted
  23. US 8188095

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  24. US 8188071

    Amino substituted pyridines as potent kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted